Cargando…
AKT mediates actinomycin D-induced p53 expression
At high cytotoxic concentrations, actinomycin D (ActD) blocks transcription, decreasing levels of MDM2 and thus causing p53 stabilization. At low cytostatic concentrations, ActD causes ribosomal stress, which decreases MDM2 activity, resulting in p53 stabilization and activation. ActD can thus be us...
Autores principales: | Chen, Chih-Shou, Ho, Dong-Ru, Chen, Fei-Yun, Chen, Chang-Rong, Ke, Yu-De, Su, Jyan-Gwo Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996664/ https://www.ncbi.nlm.nih.gov/pubmed/24525337 |
Ejemplares similares
-
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy
por: Rao, Bhavya, et al.
Publicado: (2010) -
ON THE DIFFERENTIAL CYTOTOXICITY OF ACTINOMYCIN D
por: Sawicki, Stanley G., et al.
Publicado: (1971) -
Human p53 interacts with the elongating RNAPII complex and is required for the release of actinomycin D induced transcription blockage
por: Borsos, Barbara N., et al.
Publicado: (2017) -
Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma
por: Tzaridis, Theophilos, et al.
Publicado: (2016) -
Cyproterone acetate acts as a disruptor of the aryl hydrocarbon receptor
por: Chen, Chih-Shou, et al.
Publicado: (2021)